Repeated adolescent MDMA (“Ecstasy”) exposure in rats increases behavioral and neuroendocrine responses to a 5-HT2A/2C agonist

• Published in: Brain research 2009-02, Vol.1252, p.87-93
• Main Authors: Biezonski, Dominik K, Courtemanche, Andrea B, Hong, Sang B, Piper, Brian J, Meyer, Jerrold S
• Format: Article
• Language: English
• Subjects: Amphetamines - pharmacology; Animals; Behavior, Animal - drug effects; Brain - drug effects; Brain - metabolism; Corticosterone - blood; Ketanserin - metabolism; Male; N-Methyl-3,4-methylenedioxyamphetamine - administration & dosage; Neurology; Neurosecretory Systems - drug effects; Prolactin - blood; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A - metabolism; Serotonin 5-HT2 Receptor Agonists; Serotonin Agents - pharmacology
• ISSN: 0006-8993; 1872-6240
• DOI: 10.1016/j.brainres.2008.11.045

Abstract MDMA (3,4-methylendioxymethamphetamine) is a popular recreational drug among adolescents. The present study aimed to determine the effects of repeated intermittent administration of 10 mg/kg MDMA during adolescence on behavioral (Experiment 1) and neuroendocrine (Experiment 2) responses of rats to the 5-HT2A/2C agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and on [3 H]ketanserin binding to 5-HT2A receptors. In the first experiment, MDMA pretreatment increased the frequency of head twitches and back muscle contractions, but not wet-dog shakes, to a high-dose DOI challenge. In the second experiment, both the prolactin and corticosterone responses to DOI were potentiated in MDMA-pretreated animals. No changes were found in 5-HT2A receptor binding in the hypothalamus or other forebrain areas that were examined. These results indicate that intermittent adolescent MDMA exposure enhances sensitivity of 5-HT2A/2C receptors in the CNS, possibly through changes in downstream signaling mechanisms.